![Favorite pages[Japanese page]](/files/000137013.png){kind=small}
](/files/000137010.png){kind=small}
Here begins the text.
Pmda Pharmaceuticals and Medical Devices Agency
What's newBack number
March 29, 2019PMDA Risk Communication:Sumatriptan succinate, etc. posted
- March 28, 2019PMDA Updates (March, 2019) posted
- March 28, 2019Revisions of PRECAUTIONS:Amobarbital, etc. posted
- March 26, 2019PMDA-ATC & WHO Pharmaceuticals Review Seminar 2019
- March 20, 2019List of Approved Products (New & Improved Medical Devices): FY2018 (April - September)
- March 18, 2019Report of the PMDA-ATC Pharmaceuticals Review Seminar 2019 in Jakarta, Indonesia
- March 18, 2019Report of the PMDA-ATC Pharmacovigilance Seminar 2019
- March 29, 2019PMDA Risk Communication:Sumatriptan succinate, etc. posted
- March 28, 2019Revisions of PRECAUTIONS:Amobarbital, etc. posted
- Currently, there is no applicable information.
- Currently, there is no applicable information.
- March 28, 2019PMDA Updates (March, 2019) posted
